Moreover, transgenic mice with ADAM17 overexpression presented increased macrophage infiltration and fibrosis when fed an HFD [47], whereas ADAM17 gene silencing in visceral macrophages improved AT inflammation and type 2 diabetes [48]. This evidence concerns the gene ADAM17 and type 2 diabetes mellitus.